Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Concert Pharmaceuticals, Inc.
3078
Concert Pharmaceuticals, Inc.
Health Care
Medical
Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.
Suggest edits
Type
B2b
Founded
2006
Raised
$125.5M
Follow us
Companies in the same industry
24sessions
Digital Pharmacist Inc
POZEN
myMatrixx
Intrexon
OpenQ SafeGuard
BioMarin Pharmaceutical
Abraxis BioScience
Lusomedicamenta
AIT
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$30,000,000
Post-IPO debt - 2017
Hercules Capital, Inc.
$37,000,000
Venture capital (Series C) - 2008
Adage Capital Management
Flagship Ventures
Greylock Partners
+9
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
$30,000,000
Post-IPO debt
businesswire
,
PE HUB
Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital
$48,500,000
Venture capital (Series B)
Added by
via
PE Hub
Concert Pharma Raises $48.5 Million
